Medidata and Bioforum are strengthening their decade-long partnership to advance clinical data and biometric solutions in clinical trials. This expanded collaboration aims to provide Bioforum's biotech clients with broader access to Medidata’s AI-powered technology, facilitating a more agile clinical development experience.
Enhanced Technology Integration
Building on their existing use of Medidata Rave EDC and Medidata Rave RTSM across 60 studies in various therapeutic areas, Bioforum is now incorporating Medidata Clinical Data Studio and Medidata eConsent. These additions are designed to streamline data flow, maintain data integrity, and ensure compliance, offering a comprehensive solution for managing clinical data.
AI-Driven Efficiency
Amir Malka, CEO and co-founder of Bioforum, emphasized the importance of managing clinical data securely and accurately. "With our team of experts, industry-leading biometric services, and proprietary technology, Bioforum empowers sponsors to seamlessly manage their clinical data in one place and ensure it’s secure, accurate, and ready for analysis," Malka stated. The collaboration aims to provide customers with the adaptability and advanced solutions necessary for success in clinical trials.
Janet Butler, executive vice president, head of global sales at Medidata, highlighted the benefits for agile biotech start-ups. "Our expanded partnership with Bioforum brings AI-driven clinical trial management to agile biotech start-ups, accelerating their path to market," Butler noted. By utilizing Medidata's Patient Data Surveillance and RBQM platforms, the partnership seeks to improve operational efficiency for Bioforum and provide seamless, high-quality data access for their clients.
Industry Engagement
Bioforum will sponsor Medidata’s upcoming NEXT New York conference, scheduled for November 13-14 in New York City, underscoring their commitment to advancing clinical trials through technology and collaboration.
